---
title: "TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291465084.md"
description: "TherapeuticsMD Inc. (TXMD) shares fell 2.26% to $2.16 on Wednesday, underperforming competitors like AbbVie during a broader market decline. This marks the second consecutive day of losses for the stock, which remains 26.78% below its 52-week high. Trading volume was below the 50-day average."
datetime: "2026-07-01T21:29:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291465084.md)
  - [en](https://longbridge.com/en/news/291465084.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291465084.md)
generator: "portal-rs"
---

# TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) shed 2.26% to $2.16 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.66% to 26,040.03 and Dow Jones Industrial Average falling 0.03% to 52,305.24.

This was the stock's second consecutive day of losses.

TherapeuticsMD Inc. closed 26.78% below its 52-week high of $2.95, which the company achieved on January 27th.

The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 0.23% to $251.06.

Trading volume (36,071) remained 5,047 below its 50-day average volume of 41,118.

Data source: Dow Jones Market Data, FactSet. Data compiled July 1, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-01-26 1729ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Proficio Capital Partners LLC Grows Holdings in AbbVie Inc. $ABBV](https://longbridge.com/en/news/298426046.md)
- [Apnimed, Inc. reports Q2 results](https://longbridge.com/en/news/298366495.md)
- [UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 106,091 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/298287981.md)
- [Canada Pension Plan Investment Board Buys Shares of 3,248,582 AbbVie Inc. $ABBV](https://longbridge.com/en/news/298099969.md)
- [Empowered Funds LLC Sells 24,477 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/298181607.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**